JP2013523824A5 - - Google Patents

Download PDF

Info

Publication number
JP2013523824A5
JP2013523824A5 JP2013503875A JP2013503875A JP2013523824A5 JP 2013523824 A5 JP2013523824 A5 JP 2013523824A5 JP 2013503875 A JP2013503875 A JP 2013503875A JP 2013503875 A JP2013503875 A JP 2013503875A JP 2013523824 A5 JP2013523824 A5 JP 2013523824A5
Authority
JP
Japan
Prior art keywords
tumor
composition
dna
exosomes
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013503875A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013523824A (ja
JP6025707B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/031359 external-priority patent/WO2011127129A1/en
Publication of JP2013523824A publication Critical patent/JP2013523824A/ja
Publication of JP2013523824A5 publication Critical patent/JP2013523824A5/ja
Application granted granted Critical
Publication of JP6025707B2 publication Critical patent/JP6025707B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013503875A 2010-04-06 2011-04-06 癌を治療する方法 Expired - Fee Related JP6025707B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32137010P 2010-04-06 2010-04-06
US61/321,370 2010-04-06
PCT/US2011/031359 WO2011127129A1 (en) 2010-04-06 2011-04-06 Methods of treating cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016129894A Division JP2017002054A (ja) 2010-04-06 2016-06-30 癌を治療する方法

Publications (3)

Publication Number Publication Date
JP2013523824A JP2013523824A (ja) 2013-06-17
JP2013523824A5 true JP2013523824A5 (https=) 2014-05-22
JP6025707B2 JP6025707B2 (ja) 2016-11-16

Family

ID=44763257

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013503875A Expired - Fee Related JP6025707B2 (ja) 2010-04-06 2011-04-06 癌を治療する方法
JP2016129894A Pending JP2017002054A (ja) 2010-04-06 2016-06-30 癌を治療する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016129894A Pending JP2017002054A (ja) 2010-04-06 2016-06-30 癌を治療する方法

Country Status (5)

Country Link
US (1) US9107878B2 (https=)
EP (2) EP2555627A4 (https=)
JP (2) JP6025707B2 (https=)
CN (1) CN102905534B (https=)
WO (1) WO2011127129A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2555627A4 (en) 2010-04-06 2013-10-23 John W Holaday METHOD FOR TREATING CARCINOMA
JP6272765B2 (ja) * 2012-10-01 2018-01-31 国立大学法人京都大学 ナノゲル／エキソソーム複合体とｄｄｓ
WO2017112919A1 (en) * 2015-12-23 2017-06-29 The Trustees Of Columbia University In The City Of New York Tissue-engineered three-dimensional model for tumor analysis
US10883083B2 (en) 2013-08-02 2021-01-05 The Trustees Of Columbia University In The City Of New York Tissue-engineered three-dimensional model for tumor analysis
CN104726410B (zh) * 2013-12-23 2019-09-17 浙江大学 一种具有免疫抑制功能的外排体及其应用
CN105505772B (zh) * 2015-12-07 2018-07-10 中国科学院苏州生物医学工程技术研究所 对单个外泌体进行裂解的装置
US20190125848A1 (en) * 2016-03-30 2019-05-02 Dana-Farber Cancer Institute, Inc. Dendritic cell-extracellular vesicle fusions and methods of using same
JP2018070572A (ja) * 2016-10-24 2018-05-10 義之 小山 免疫治療システム
JP6613499B2 (ja) 2017-08-24 2019-12-04 学校法人藤田学園 細胞殺傷剤
JP7282874B2 (ja) * 2018-08-20 2023-05-29 中国科学院過程工程研究所 エクソソームに基づく抗腫瘍ワクチン
JP6635637B1 (ja) * 2018-11-22 2020-01-29 株式会社細胞治療技術研究所 免疫療法ワクチンの製造方法
CN110036976B (zh) * 2019-05-08 2021-12-07 华南农业大学 一种阻断鸡禽白血病病毒垂直传播的方法及其应用
CN111759862A (zh) * 2020-06-04 2020-10-13 江苏大学 干细胞外泌体在制备抗结肠炎恶化药物中的应用
JP7160963B2 (ja) * 2021-01-15 2022-10-25 Ｖａｘｏｓｏｍｅ合同会社 細胞外粒子の製造方法
JP7079901B1 (ja) * 2021-08-24 2022-06-02 Ｖａｘｏｓｏｍｅ合同会社 細胞外粒子の産生方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605885A (en) 1988-05-05 1997-02-25 Entremed, Inc. Method for stimulating the immune system
ATE272311T1 (de) 1993-03-23 2004-08-15 Cbr Lab Inc Verfahren und vorrichtung zur einkapselung biologisch aktiver substanzen in zellen
DE4410136A1 (de) * 1993-03-31 1994-10-06 Boehringer Mannheim Gmbh Tumorizide T-Lymphozyten
CA2162853A1 (en) * 1993-05-14 1994-11-24 Jozephus Carolus Martha Raus Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer
US5610013A (en) * 1993-07-22 1997-03-11 Ludwig Institute For Cancer Research Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
US6773669B1 (en) 1995-03-10 2004-08-10 Maxcyte, Inc. Flow electroporation chamber and method
US6074605A (en) 1995-03-10 2000-06-13 Entremed, Inc. Flow electroporation chamber and method
US5720921A (en) 1995-03-10 1998-02-24 Entremed, Inc. Flow electroporation chamber and method
US6090617A (en) 1996-12-05 2000-07-18 Entremed, Inc. Flow electroporation chamber with electrodes having a crystalline metal nitride coating
FR2766205B1 (fr) * 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US20020022036A1 (en) * 2000-08-21 2002-02-21 Riordan Neil H. Method for inducing an anti-tumor and anti-cachexia immune response in mammals
US7029916B2 (en) 2001-02-21 2006-04-18 Maxcyte, Inc. Apparatus and method for flow electroporation of biological samples
FR2827872A1 (fr) * 2001-07-30 2003-01-31 Roussy Inst Gustave Vesicules membranaires de fluide biologique preleve in vivo, leur preparation et utilisation dans la stimulation d'une reponse immunitaire
EP2574662B1 (en) 2001-08-22 2021-08-04 Maxcyte, Inc. Method for electroporation of biological samples
AU2003277109A1 (en) 2002-09-30 2004-04-23 Maxcyte, Inc. Apparatus and method for streaming electroporation
CN1446583A (zh) * 2002-11-29 2003-10-08 帕弗瑞生物技术(北京)有限公司 一种肿瘤免疫治疗及预防性疫苗的组成、制备、应用方案
WO2004053095A2 (en) * 2002-12-10 2004-06-24 Merix Bioscience, Inc. In situ maturation of dendritic cells
WO2004071518A1 (ja) 2003-02-17 2004-08-26 Mebiopharm Co., Ltd. 癌治療薬
JP2006518219A (ja) * 2003-02-18 2006-08-10 マックスサイト インコーポレーティッド 電気穿孔法による細胞への抗原の負荷方法
US20060134067A1 (en) * 2003-02-18 2006-06-22 Maxcyte, Inc. Loading of cells with antigens by electroporation
WO2005026318A2 (en) * 2003-07-31 2005-03-24 Endacea, Inc. Methods and compositions for producing antigenic responses
KR101131727B1 (ko) * 2004-06-11 2012-03-28 가톨릭대학교 산학협력단 ＣＥＡ-특이적인 세포독성 Ｔ세포를 생성하는 재조합 아데노바이러스 ＡｄＶＣＥＡ로 트랜스덕션된 수지상세포, 이를 포함하는 백신 및 약제학적 조성물
US8338173B2 (en) * 2005-08-11 2012-12-25 University College Cardiff Consultants Limited Preparation of antigen-presenting human γδ T cells and use in immunotherapy
JP4824389B2 (ja) 2005-10-28 2011-11-30 株式会社医学生物学研究所 エプスタイン−バールウイルス感染細胞を特異的に攻撃する細胞傷害性ｔ細胞エピトープペプチド及びその用途
CN101085349B (zh) * 2006-06-09 2011-05-25 项雯华 囊泡导向的免疫细胞及其在制备抗肿瘤药物上的应用
HUE035406T2 (en) * 2007-10-08 2018-05-02 Intrexon Corp Engineered dendritic cells and uses for the treatment of cancer
KR20090047290A (ko) * 2007-11-07 2009-05-12 주식회사 바이오인프라 엑소좀 및 이를 함유한 암 백신 조성물
KR101076879B1 (ko) 2008-04-11 2011-10-25 주식회사 하이닉스반도체 셀프 부스팅을 이용한 플래시 메모리소자의 프로그램 방법
CA2728739C (en) 2008-06-20 2017-07-11 Duke University Use of human cytomegalovirus antigens to enhance immune responses to cancer cells
EP2555627A4 (en) 2010-04-06 2013-10-23 John W Holaday METHOD FOR TREATING CARCINOMA

Similar Documents

Publication Publication Date Title
JP2013523824A5 (https=)
Pavkov-Keller et al. The structure of bacterial S-layer proteins
Bai et al. A paradoxical role for neutrophils in the pathogenesis of West Nile virus
Adamek et al. Cyprinid herpesvirus 3 infection disrupts the skin barrier of common carp (Cyprinus carpio L.)
EP3101141A3 (en) Method for methylation analysis
EP3076949A4 (en) Analysis of genomic dna, rna, and proteins in exosomes for diagnosis and theranosis
SG11201500371VA (en) Methods of detecting dna, rna and protein in biological samples
WO2015200717A3 (en) Pcr-activated sorting (pas)
EP2361930A3 (en) Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
WO2016064894A3 (en) Compositions and methods for detecting an rna virus
WO2012122564A3 (en) Diagnostic and sample preparation devices and methods
JP2010533200A5 (https=)
JP2016198116A5 (https=)
SG10201903822XA (en) Method for the enrichment of circulating tumor dna
BRPI0820177A2 (pt) Métodos para produzir um extrato de proteína a partir de células fixadas ou não-fixadas e para detectar uma proteína alvo, sistema para produzir um extrato de proteína, kit para produzir um extrato de proteína de células fixadas ou não-fixadas, e, método para extrair uma proteína viral alvo de uma amostra celular
WO2007133682A3 (en) 100% sequence identity detection methods for variable genomes
Takagi et al. Transcriptome analyses of immune system behaviors in primary polyp of coral Acropora digitifera exposed to the bacterial pathogen Vibrio coralliilyticus under thermal loading
EP2631649A8 (en) Method and device for the rapid diagnosis of diseases in faecal samples
EP2853895A3 (en) Methods, apparatus and systems for detection of total protein using capillary electrophoresis
BR112014029274A2 (pt) anticorpo isolado, composição farmacêutica, uso do anticorpo, método para tratar infecção rábica, kit para tratar infecção rábica, kit para detectar vírus rábico, ácido nucleico isolado, e, célula hospedeira.
JP2012524523A5 (https=)
MX2021007292A (es) Composiciones de conjugados de estreptavidina-oligo de ocupación de pmhc.
BRPI0917462A2 (pt) sistema automatizado para seleção e intermediação de células biológicas alógenas armazenadas para transplante, terapia e pesquisa
EP2443260A4 (en) VIRAL ANALYSIS
WO2012177930A8 (en) System for handling biological samples